Treatment recommendations for high-risk biochemical recurrent prostate cancer



Channing Paller, MD, The Johns Hopkins University, Baltimore, MD, discusses systemic treatment options for patients with …

source

Leave a Reply

Your email address will not be published. Required fields are marked *